A translational worksite diabetes prevention trial improves psychosocial status, dietary intake, and step counts among employees with prediabetes: A randomized controlled trial

• Main Authors: Carla K. Miller, Kellie R. Weinhold, David G. Marrero, Haikady N. Nagaraja, Brian C. Focht
• Format: Article
• Language: English
• Published: Elsevier 2015-01-01
• Series: Preventive Medicine Reports
• Subjects: Prediabetes; Randomized controlled trial; Self-efficacy; Goal setting; Dietary intake; Physical activity
• Online Access: http://www.sciencedirect.com/science/article/pii/S2211335515000133

Objective: Few worksite trials have examined the impact of diabetes prevention interventions on psychological and behavioral outcomes. Thus, the impact of a worksite lifestyle intervention on psychosocial outcomes, food group intake, and step counts for physical activity (PA) was evaluated. Method: A randomized pretest/posttest control group design with 3-month follow-up was employed from October 2012 to May 2014 at a U.S. university worksite among employees with prediabetes. The experimental group (n = 35) received a 16-week group-based intervention while the control group received usual care (n = 33). Repeated measures analysis of variance compared the change in outcomes between groups across time. Results: A significant difference occurred between groups post-intervention for self-efficacy associated with eating and PA; goal commitment and difficulty; satisfaction with weight loss and physical fitness; peer social support for healthful eating; generation of alternatives for problem solving; and intake of fruits, meat, fish, poultry, nuts, and seeds (all ps < .05). The experimental group significantly increased step counts post-intervention (p = .0279) and were significantly more likely to report completing their work at study end (p = .0231). Conclusion: The worksite trial facilitated improvement in modifiable psychosocial outcomes, dietary patterns, and step counts; the long-term impact on diabetes prevention warrants further investigation. Trial Registration: ClinicalTrials.gov identifier: NCT01682954